AI-generated summary
The authors studied whether 670 nm low-level laser therapy changes the viability of normal human osteoblasts and osteosarcoma cells exposed to cisplatin or zoledronic acid in cell culture. They report that laser alone increased viability in both cell types, while laser combined with the highest drug concentrations lowered viability, and suggest this could inform future treatments for bone tumours. These are in vitro results only.
- Who or what was studied
- Primary human osteoblasts and the Saos-2 osteosarcoma cell line, studied in vitro
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The study was conducted only in vitro, so the findings may not apply to living patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 670 nm
- Power density (irradiance)
- 100mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Photodynamic therapy, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.